市场调查报告书
商品编码
1435056
抗缪勒氏管激素测试市场:按产品、最终用户、分布和应用 - 2024-2030 年全球预测Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年抗苗勒管激素检测市场规模为2.7426亿美元,预计2024年将达3.0541亿美元,2030年将达到5.8648亿美元,复合年增长率为11.46%。
抗苗勒氏管激素检测的全球市场
主要市场统计 | |
---|---|
基准年[2023] | 27426万美元 |
预测年份 [2024] | 30541万美元 |
预测年份 [2030] | 5.8648亿美元 |
复合年增长率(%) | 11.46% |
抗苗勒氏管激素 (AMH) 测试是医疗专业人员用来评估女性卵巢储备、生育能力和生殖健康的诊断工具。 AMH是由卵巢前週期卵泡和肛门卵泡的颗粒细胞产生的一种糖蛋白激素,透过抑制发育中的原始卵泡募集到卵泡中,在调节卵泡发育中发挥重要作用。我正在履行我的职责。测量 AMH 水平可以告诉我们女性的卵巢储备情况以及可能发育成健康胚胎的卵子数量。 AMH 检测在临床上也可用于诊断卵巢症候群 (PCOS)。卵巢症候群是一种常见的内分泌疾病,会增加月经和不孕的风险。 AMH 测试是评估接受化疗和骨盆腔放射线治疗等治疗的癌症患者发生卵巢早衰 (POI) 和提前闭经的风险的重要工具。在这些治疗之前、期间和之后监测 AMH 水平可以帮助识别 POI 高风险患者,并指导采取适当措施以保留生育选择。此外,由于女性健康疾病的增加以及体外受精和卵子冷冻治疗的增加,对 AMH 检测的需求也在增加。然而,家庭诊断套件结果不一致以及报销方案不明确严重阻碍了 AMH 检测的采用。此外,FDA核准针对更年期疾病的 AMH 检测以及在新兴市场采用自动化 AMH 检测预计将提供重要的市场开拓机会。
区域洞察
在美洲,由于人们对不孕症的兴趣增加、研发 (R&D) 力度加大以及 FDA 对 AMH 的核准迅速增加,AMH 市场正在经历显着增长。由于产品开发和女性不孕症的增加,美国和加拿大在 AMH 市场的区域前景中处于领先地位。在墨西哥、阿根廷和巴西,快速的都市化对不孕症的下降做出了重大贡献,这主要是由于这些国家发生的重大社会、经济和政治变革进一步促进了 AMH 检测市场的成长。 。在亚太地区,由于生育中心和实验室数量的增加、公众意识、医疗保健及相关基础设施的投资以及政府对 AMH 检测的支持政策,预计 AMH 检测市场将显着增长。随着需求和采用的增加,中国、日本、印度、澳洲和新加坡等主要国家看到了女性不孕症治疗的正面前景。同时,在中东和非洲,阿联酋、沙乌地阿拉伯、南非等主要经济体在医疗保健领域也逐步取得了一些进展。此外,随着政府更加重视提供支援措施以及私人医疗保健和製药公司的意识和投资的增加,欧洲、中东和非洲地区的市场潜力预计将扩大。
FPNV定位矩阵
FPNV定位矩阵对于评估抗苗勒氏管激素检测市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对抗苗勒管激素测试市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2-市场开拓:我们深入研究利润丰厚的新兴市场并分析其在成熟细分市场的渗透率。
3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1-抗苗勒氏管激素检测市场的市场规模与预测是多少?
2-在抗苗勒管激素测试市场的预测期内,有哪些产品、细分市场、应用和领域需要考虑投资?
3-抗苗勒管激素检测市场的技术趋势和法律规范是什么?
4-抗苗勒管激素测试市场主要供应商的市场占有率是多少?
5-进入抗苗勒氏管激素检测市场合适的型态与策略手段是什么?
[184 Pages Report] The Anti-Mullerian Hormone Test Market size was estimated at USD 274.26 million in 2023 and expected to reach USD 305.41 million in 2024, at a CAGR 11.46% to reach USD 586.48 million by 2030.
Global Anti-Mullerian Hormone Test Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 274.26 million |
Estimated Year [2024] | USD 305.41 million |
Forecast Year [2030] | USD 586.48 million |
CAGR (%) | 11.46% |
The anti-mullerian hormone (AMH) test is a diagnostic tool healthcare professionals utilize to evaluate ovarian reserve, fertility potential, and reproductive health in women. AMH is a glycoprotein hormone created by the granulosa cells of pre-antral and antral follicles in the ovaries which plays a crucial role in regulating follicular development by inhibiting the recruitment of primordial follicles into the growing pool. Measuring AMH levels provides valuable insights into a woman's ovarian reserve, which directs to the number of eggs that can potentially develop into healthy embryos. The AMH test also has clinical utility in diagnosing polycystic ovary syndrome (PCOS), a common endocrine disorder causing irregular menstrual cycles and increased risk of infertility. AMH testing serves as an invaluable tool for assessing the risk of premature ovarian insufficiency (POI) or early menopause in cancer patients undergoing treatments such as chemotherapy or pelvic radiation therapy. Monitoring AMH levels before, during, and after these therapies help identify individuals at higher risk for POI and guide appropriate measures to preserve their fertility options. Moreover, the rising number of women's health diseases and the growing number of IVF and egg-freezing procedures raised the need for AMH tests. However, inconsistent results of in-home diagnostics kits and unclear reimbursement options significantly impede the adoption of AMH tests. In addition, emerging FDA approval of AMH test in menopausal status and the emerging adoption of automated AMH tests is expected to create tremendous opportunities for market development.
Regional Insights
In the Americas, the anti-mullerian hormone test market has experienced substantial growth due to increasing infertility concerns, rising research and development (R&D) efforts, and the surging number of approvals in AMH by the FDA in the recent period. The U.S. and Canada are heading the regional AMH market landscape with product development and increased infertility in women. In Mexico, Argentina, and Brazil, the rapid urbanization process significantly contributes to the fertility decrease, primarily linked to the country's significant social, economic, and political transformations, further contributing to the AMH test market growth. In the Asia-Pacific, the AMH test market is expected to grow significantly due to increasing infertility treatment centers & laboratories, awareness among the population, investment in healthcare & related infrastructure, and supportive government policies for AMH tests. The major economies, including China, Japan, India, Australia, and Singapore, offer positive prospects with increasing demand and adoption of female fertility care. In the EMEA region, the developed European economies represent the advanced landscape, whereas, in the Middle East & Africa, the major economies such as UAE, Saudi Arabia, and South Africa are gradually moving ahead with several developments in the healthcare sector. Moreover, rising governments focus on providing supportive measures and raising awareness and investment from private healthcare, and pharmaceutical companies are expected to expand the market's potential in the EMEA region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Anti-Mullerian Hormone Test Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anti-Mullerian Hormone Test Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Anti-Mullerian Hormone Test Market, highlighting leading vendors and their innovative profiles. These include Abbexa Ltd., Ansh Labs, Athenese-Dx, BioMerieux SA, Chengdu VACURE Biotechnology Co., Ltd., CTK Biotech, Inc., Cusabio Technology LLC, Danaher Corporation, Doctorcall Limited, Eagle Biosciences, Inc., Elabscience, Inc., enQuire Bio, LLC, F. Hoffmann-La Roche AG, Fertility 2 U Ltd, Goldsite Diagnostics Inc., Kamiya Biomedical Co, LifeSpan BioSciences, Inc., London Gynaecology Ltd., Meridian Life Science, Inc. by SD Biosensor, Monobind Inc., Tosoh Corporation, Vitall by Healthy Human Labs Ltd., Vitrosens Biotechnology, and Walk-In Lab, LLC.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Anti-Mullerian Hormone Test Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anti-Mullerian Hormone Test Market?
3. What are the technology trends and regulatory frameworks in the Anti-Mullerian Hormone Test Market?
4. What is the market share of the leading vendors in the Anti-Mullerian Hormone Test Market?
5. Which modes and strategic moves are suitable for entering the Anti-Mullerian Hormone Test Market?